Recruiting
Readiness and Progress in Emotion Regulation Therapy
This study is an open trial designed to examine individual changes that occur before, during, and after 6 modules of Emotion Regulation Therapy (ERT) delivered via telehealth for individuals in New York State who are experiencing elevated worry, rumination, or self-criticism.
ClinicalTrials.gov IDNCT07478393
PhaseNA
Enrollment36
SponsorTeachers College, Columbia University
Age18 Years
SexALL
Conditions studied
Rumination, Worry, Self-Criticism, Anxiety, Depression, Distress, Emotional
About this study
This study is an open trial designed to examine individual changes that occur before, during, and after 6 modules of Emotion Regulation Therapy (ERT) delivered via telehealth for individuals in New York State who are experiencing elevated worry, rumination, or self-criticism.
Interventions
- Behavioral: Emotion Regulation Therapy via Telehealth — The initial stage of treatment focuses on psychoeducation about anxiety/depression, the impact that these cognitions/behaviors/emotions have on recent situations, and self-monitoring of worry/anxiety/depression. The sessions focus on the development of skills that help understand and regulate one's emotional experience (i.e., recognizing emotions when they are happening, identifying the meaning of a given emotion experience, soothing oneself in the context of negative emotional experiences). Following the development of these skills, sessions focus on the application of somatic awareness and emotion regulation skills while imagining emotionally evocative themes. The remaining session focuses on terminating therapy, relapse prevention, and future goals. An Internet-based online platform will be used to promote engagement with and increase accessibility to between-session skills practice and treatment-related activities (e.g., self-monitoring, session summaries, worksheets).
Primary outcomes
- Weekly Assessment of Change in Attentional Control (Weekly from Baseline (2 weeks) through Treatment (12-22 weeks) and Follow-Up (4 weeks))
- Weekly Assessment of Change in Decentering (Weekly from Baseline (2 weeks) through Treatment (12-22 weeks) and Follow-Up (4 weeks))
- Weekly Assessment of Change in Reappraisal (Weekly from Baseline (2 weeks) through Treatment (12-22 weeks) and Follow-Up (4 weeks))
- Weekly Assessment of Change in Valued Living/Action (Baseline, 1st Treatment Session, Follow-Up (4 weeks))
- Weekly Assessment of Change in Clarity of Approach-Avoidance Motivation (Baseline, 1st Treatment Session, Follow-Up (4 weeks))
- Weekly Assessment of Change in Rumination (Weekly from Baseline (2 weeks) through Treatment (12-22 weeks) and Follow-Up (4 weeks))
- Weekly Assessment of Change in Worry (Weekly from Baseline (2 weeks) through Treatment (12-22 weeks) and Follow-Up (4 weeks))
- Weekly Assessment of Change in Self-Criticism (Weekly from Baseline (2 weeks) through Treatment (12-22 weeks) and Follow-Up (4 weeks))
Eligibility information
Inclusion Criteria:
* Between the ages of 18 and 65
* Fluent in English (and therefore able to provide consent)
* Currently living in New York State
* Access to at least one device with internet and video-conferencing capabilities
* High self-reported worry, rumination, and/or self-criticism
* Meet Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5) criteria for at least one, current psychological disorder
Exclusion Criteria:
* Active suicidal ideation or intent
* Substance dependence disorder, schizophrenia, bipolar-I disorder, or a primary DSM-5 diagnosis of borderline or narcissistic personality disorder
* Currently in therapy or receiving any type of psychosocial treatment
* Individuals taking psychotropic mediation that has not been stabilized for a period of at least 3 months
* Current students at Teachers College, Columbia University
Study locations
- Teachers College, Columbia University, New York, New York 10027 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-29.